Published in Exp Brain Res on November 27, 2007
Ischaemia differentially regulates GABA(B) receptor subunits in organotypic hippocampal slice cultures. Neuropharmacology (2009) 0.92
Novel application of stem cell-derived neurons to evaluate the time- and dose-dependent progression of excitotoxic injury. PLoS One (2013) 0.84
Adenosine A1 receptors contribute to immune regulation after neonatal hypoxic ischemic brain injury. Purinergic Signal (2015) 0.82
Organic silicon protects human neuroblastoma SH-SY5Y cells against hydrogen peroxide effects. BMC Complement Altern Med (2014) 0.82
XENON in medical area: emphasis on neuroprotection in hypoxia and anesthesia. Med Gas Res (2013) 0.78
Igf1 and Pacap rescue cerebellar granule neurons from apoptosis via a common transcriptional program. Cell Death Discov (2015) 0.76
Oxidative stress, glutamate, and neurodegenerative disorders. Science (1993) 7.96
The metabotropic glutamate receptors: structure and functions. Neuropharmacology (1995) 5.11
The role of divalent cations in the N-methyl-D-aspartate responses of mouse central neurones in culture. J Physiol (1988) 4.91
Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function. Neuron (1995) 4.07
Adenosine 5'-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation. Pharmacol Ther (2006) 3.93
An iontophoretic investigation of the actions of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid. Brain Res (1982) 2.99
Glutamate neurotoxicity in cortical cell culture. J Neurosci (1987) 2.98
A(2A) adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice. J Neurosci (1999) 2.92
Adenosine in the central nervous system: release mechanisms and extracellular concentrations. J Neurochem (2001) 2.63
Endogenous kynurenines as targets for drug discovery and development. Nat Rev Drug Discov (2002) 2.61
The in vitro pharmacology of ZM 241385, a potent, non-xanthine A2a selective adenosine receptor antagonist. Br J Pharmacol (1995) 2.38
Neurodegeneration in excitotoxicity, global cerebral ischemia, and target deprivation: A perspective on the contributions of apoptosis and necrosis. Brain Res Bull (1998) 2.26
Activation and involvement of p38 mitogen-activated protein kinase in glutamate-induced apoptosis in rat cerebellar granule cells. J Biol Chem (1997) 2.02
Adenosine inhibits evoked synaptic transmission primarily by reducing presynaptic calcium influx in area CA1 of hippocampus. Neuron (1994) 1.86
Cell cycle regulation of neuronal apoptosis in development and disease. Prog Neurobiol (2004) 1.75
Kynurenic acid antagonises responses to NMDA via an action at the strychnine-insensitive glycine receptor. Eur J Pharmacol (1988) 1.37
Molecular mechanisms of cerebral ischemia-induced neuronal death. Int Rev Cytol (2002) 1.33
Deadly conversations: nuclear-mitochondrial cross-talk. J Bioenerg Biomembr (2004) 1.31
Activation of a caspase 3-related cysteine protease is required for glutamate-mediated apoptosis of cultured cerebellar granule neurons. Proc Natl Acad Sci U S A (1997) 1.24
Hydrogen peroxide-induced oxidative stress in MC3T3-E1 cells: The effects of glutamate and protection by purines. Bone (2006) 1.21
Calpain-cleaved collapsin response mediator protein-3 induces neuronal death after glutamate toxicity and cerebral ischemia. J Neurosci (2006) 1.14
Glutamate-induced neuronal death is not a programmed cell death in cerebellar culture. J Neurochem (1993) 1.09
Blockade of adenosine A2A receptors by SCH 58261 results in neuroprotective effects in cerebral ischaemia in rats. Neuroreport (1998) 1.08
Neuronal death in vitro: parallelism between survivability of hippocampal neurones and sustained elevation of cytosolic Ca2+ after exposure to glutamate receptor agonist. Exp Brain Res (1988) 1.08
Glutamate triggers internucleosomal DNA cleavage in neuronal cells. Biochem Biophys Res Commun (1991) 1.08
The effects of selective A1 and A2a adenosine receptor antagonists on cerebral ischemic injury in the gerbil. Brain Res (1995) 1.05
Kynurenine hydroxylase inhibitors reduce ischemic brain damage: studies with (m-nitrobenzoyl)-alanine (mNBA) and 3,4-dimethoxy-[-N-4-(nitrophenyl)thiazol-2yl]-benzenesulfonamide (Ro 61-8048) in models of focal or global brain ischemia. J Cereb Blood Flow Metab (1999) 1.03
Depolarization or glutamate receptor activation blocks apoptotic cell death of cultured cerebellar granule neurons. Brain Res (1994) 1.03
Neuroprotection by caffeine and adenosine A2A receptor blockade of beta-amyloid neurotoxicity. Br J Pharmacol (2003) 1.01
CGS 15943, an adenosine A2 receptor antagonist, reduces cerebral ischemic injury in the Mongolian gerbil. Life Sci (1994) 1.01
Protection against kainate-induced excitotoxicity by adenosine A2A receptor agonists and antagonists. Neuroscience (1998) 1.00
Purines and neuroprotection. Adv Exp Med Biol (2002) 1.00
Poly(ADP-ribose) polymerase inhibitors attenuate necrotic but not apoptotic neuronal death in experimental models of cerebral ischemia. Cell Death Differ (2001) 0.99
The A2a/A2b receptor antagonist ZM-241385 blocks the cardioprotective effect of adenosine agonist pretreatment in in vivo rat myocardium. Am J Physiol Heart Circ Physiol (2006) 0.98
Adenosine reduces cortical neuronal injury induced by oxygen or glucose deprivation in vitro. Neurosci Lett (1988) 0.96
Inhibition of NMDA receptor-mediated currents in isolated rat hippocampal neurones by adenosine A1 receptor activation. Neuroreport (1995) 0.94
Adenosinergic protection of dopaminergic and GABAergic neurons against mitochondrial inhibition through receptors located in the substantia nigra and striatum, respectively. J Neurosci (2003) 0.93
Brain adenosine receptors as targets for therapeutic intervention in neurodegenerative diseases. Ann N Y Acad Sci (1999) 0.91
Poly(ADP-ribose) polymerase: early involvement in glutamate-induced neurotoxicity in cultured cerebellar granule cells. J Neurosci Res (1994) 0.90
Neither energy collapse nor transcription underlie in vitro neurotoxicity of poly(ADP-ribose) polymerase hyper-activation. Neurochem Int (2006) 0.90
Protection against hippocampal kainate excitotoxicity by intracerebral administration of an adenosine A2A receptor antagonist. Brain Res (1998) 0.89
Interleukin-1beta but not tumor necrosis factor-alpha potentiates neuronal damage by quinolinic acid: protection by an adenosine A2A receptor antagonist. J Neurosci Res (2007) 0.88
Neurotoxicity of tryptophan metabolites. Biochem Soc Trans (2007) 0.87
Cyclosporin A targets involved in protection against glutamate excitotoxicity. Eur J Pharmacol (2000) 0.87
Adenosine A2A receptor-induced inhibition of NMDA and GABAA receptor-mediated synaptic currents in a subpopulation of rat striatal neurons. Neuropharmacology (2004) 0.84
Involvement of the transcription factor E2F1/Rb in kainic acid-induced death of murine cerebellar granule cells. Brain Res Mol Brain Res (2003) 0.84
Staurosporine-induced apoptosis in astrocytes is prevented by A1 adenosine receptor activation. Neurosci Lett (2007) 0.83
Rapid uncoupling of oxidative phosphorylation accompanies glutamate toxicity in rat cerebellar granule cells. Neuroreport (1996) 0.83
Glutamate antagonists in therapy of stroke. Restor Neurol Neurosci (1998) 0.82
Adenosine, neurodegeneration and neuroprotection. Neurol Res (2005) 0.82
Cell death in rat cerebellar granule neurons induced by hydrogen peroxide in vitro: mechanisms and protection by adenosine receptor ligands. Brain Res (2006) 0.82
Nicotinylalanine increases cerebral kynurenic acid content and has anticonvulsant activity. Gen Pharmacol (1992) 0.81
Quinolinic acid neurotoxicity: protection by intracerebral phenylisopropyladenosine (PIA) and potentiation by hypotension. Neurosci Lett (1989) 0.81
Glial metabolites of tryptophan and excitotoxicity: coming unglued. Exp Neurol (2005) 0.81
Different roles of adenosine A1, A2A and A3 receptors in controlling kainate-induced toxicity in cortical cultured neurons. Neurochem Int (2005) 0.81
Kynurenine 3-mono-oxygenase inhibitors attenuate post-ischemic neuronal death in organotypic hippocampal slice cultures. J Neurochem (2002) 0.79
Protection against acute MPTP-induced dopamine depletion in mice by adenosine A1 agonist. J Neurochem (1993) 0.79
Adenosine promotes neuronal recovery from reactive oxygen species induced lesion in rat hippocampal slices. Neurosci Lett (2003) 0.79
AMPA neurotoxicity in cultured cerebellar granule neurons: mode of cell death. Brain Res Bull (1997) 0.78
Valerian extract Ze 911 inhibits postsynaptic potentials by activation of adenosine A1 receptors in rat cortical neurons. Planta Med (2006) 0.77
Spermine-induced toxicity in cerebellar granule neurons is independent of its actions at NMDA receptors. J Neurochem (2000) 0.77
Adenosine reduces glutamate release in rat spinal synaptosomes. Anesthesiology (2005) 0.77
Block by N6-L-phenylisopropyl-adenosine of the electrophysiological and morphological correlates of hippocampal ischaemic injury in the gerbil. Br J Pharmacol (1996) 0.77
Group B vitamins protect murine cerebellar granule cells from glutamate/NMDA toxicity. Neuroreport (2004) 0.77
Detection of high molecular weight DNA fragments characteristic of early stage apoptosis in cerebellar granule cells exposed to glutamate. Exp Brain Res (2000) 0.76
ZM 241385, an adenosine A(2A) receptor antagonist, inhibits hippocampal A(1) receptor responses. Eur J Pharmacol (1999) 0.76
Role of kynurenines in the neurotoxic actions of kainic acid. Br J Pharmacol (2000) 0.76
Characterization of [3H]ZM 241385 binding in wild-type and adenosine A2A receptor knockout mice. Eur J Pharmacol (2004) 0.75
Effect of an adenosine A(1) receptor agonist and a novel pyrimidoindole on membrane properties and neurotransmitter release in rat cortical and hippocampal neurons. Neurochem Int (2001) 0.75
Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology (2008) 15.86
Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin (2008) 12.90
American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin (2007) 12.19
American Cancer Society guideline for the early detection of prostate cancer: update 2010. CA Cancer J Clin (2010) 6.45
American Cancer Society guideline for the early detection of cervical neoplasia and cancer. CA Cancer J Clin (2002) 5.56
Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening. Lancet (2003) 5.40
Swedish two-county trial: impact of mammographic screening on breast cancer mortality during 3 decades. Radiology (2011) 5.17
Absolute numbers of lives saved and overdiagnosis in breast cancer screening, from a randomized trial and from the Breast Screening Programme in England. J Med Screen (2010) 4.72
Worldwide variations in colorectal cancer. CA Cancer J Clin (2009) 4.71
Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. Gastroenterology (2006) 4.57
Supplemental oxygen impairs detection of hypoventilation by pulse oximetry. Chest (2004) 3.55
Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. CA Cancer J Clin (2006) 3.21
American Cancer Society lung cancer screening guidelines. CA Cancer J Clin (2013) 3.16
A national survey of primary care physicians' methods for screening for fecal occult blood. Ann Intern Med (2005) 3.01
Preventing cancer, cardiovascular disease, and diabetes: a common agenda for the American Cancer Society, the American Diabetes Association, and the American Heart Association. Circulation (2004) 2.91
The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish counties. Cancer (2002) 2.85
The efficacy and safety of pain management before and after implementation of hospital-wide pain management standards: is patient safety compromised by treatment based solely on numerical pain ratings? Anesth Analg (2005) 2.83
Standardized colonoscopy reporting and data system: report of the Quality Assurance Task Group of the National Colorectal Cancer Roundtable. Gastrointest Endosc (2007) 2.82
American Cancer Society Guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors. CA Cancer J Clin (2007) 2.81
Counterpoint: Overdiagnosis in breast cancer screening. J Am Coll Radiol (2014) 2.75
International Association for the Study of Lung Cancer Computed Tomography Screening Workshop 2011 report. J Thorac Oncol (2012) 2.45
Colorectal cancer screening: a comparison of 35 initiatives in 17 countries. Int J Cancer (2008) 2.41
Insights from the breast cancer screening trials: how screening affects the natural history of breast cancer and implications for evaluating service screening programs. Breast J (2014) 2.37
Sequential design approaches for bioequivalence studies with crossover designs. Pharm Stat (2008) 2.33
Guideline implementation for breast healthcare in low-income and middle-income countries: overview of the Breast Health Global Initiative Global Summit 2007. Cancer (2008) 2.28
Systematic review: surveillance for breast cancer in women treated with chest radiation for childhood, adolescent, or young adult cancer. Ann Intern Med (2010) 2.17
Clinical impacts of mammalian target of rapamycin expression in human colorectal cancers. Hum Pathol (2013) 2.09
Identifying minimally acceptable interpretive performance criteria for screening mammography. Radiology (2010) 2.06
Correlates of underutilization of colorectal cancer screening among U.S. adults, age 50 years and older. Prev Med (2003) 2.05
Guideline implementation for breast healthcare in low- and middle-income countries: early detection resource allocation. Cancer (2008) 1.90
Guidelines for colonoscopy surveillance after cancer resection: a consensus update by the American Cancer Society and the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology (2006) 1.89
Modelling the cumulative risk of a false-positive screening test. Stat Methods Med Res (2010) 1.87
Promoting early detection tests for colorectal carcinoma and adenomatous polyps: a framework for action: the strategic plan of the National Colorectal Cancer Roundtable. Cancer (2002) 1.87
Breast cancer in limited-resource countries: an overview of the Breast Health Global Initiative 2005 guidelines. Breast J (2006) 1.85
Influence of annual interpretive volume on screening mammography performance in the United States. Radiology (2011) 1.81
Colorectal cancer screening barriers and facilitators in older persons. Prev Med (2009) 1.73
A perspective from countries using organized screening programs. Cancer (2004) 1.72
Mammographic tumor features can predict long-term outcomes reliably in women with 1-14-mm invasive breast carcinoma. Cancer (2004) 1.70
Effect of baseline breast density on breast cancer incidence, stage, mortality, and screening parameters: 25-year follow-up of a Swedish mammographic screening. Cancer Epidemiol Biomarkers Prev (2010) 1.69
Revised colorectal screening guidelines: joint effort of the American Cancer Society, U.S. Multisociety Task Force on Colorectal Cancer, and American College of Radiology. Radiology (2008) 1.60
Progression rates of colorectal cancer by Dukes' stage in a high-risk group: analysis of selective colorectal cancer screening. Cancer J (2004) 1.53
Colonoscopy surveillance after polypectomy and colorectal cancer resection. Am Fam Physician (2008) 1.52
Carcinoma ex pleomorphic adenoma: a comprehensive review of clinical, pathological and molecular data. Head Neck Pathol (2011) 1.52
Mammographic screening and "overdiagnosis". Radiology (2011) 1.48
Emerging technologies in screening for colorectal cancer: CT colonography, immunochemical fecal occult blood tests, and stool screening using molecular markers. CA Cancer J Clin (2003) 1.44
Prevention and early detection clinical trials: opportunities for primary care providers and their patients. CA Cancer J Clin (2003) 1.41
Professional and economic factors affecting access to mammography: a crisis today, or tomorrow? Results from a national survey. Cancer (2005) 1.38
Guidelines for colonoscopy surveillance after cancer resection: a consensus update by the American Cancer Society and US Multi-Society Task Force on Colorectal Cancer. CA Cancer J Clin (2006) 1.33
Emergence of multiclass drug-resistance in HIV-2 in antiretroviral-treated individuals in Senegal: implications for HIV-2 treatment in resouce-limited West Africa. Clin Infect Dis (2009) 1.33
Survey of radiology residents: breast imaging training and attitudes. Radiology (2003) 1.26
Asthma outcomes: healthcare utilization and costs. J Allergy Clin Immunol (2012) 1.23
Hydrogen peroxide-induced oxidative stress in MC3T3-E1 cells: The effects of glutamate and protection by purines. Bone (2006) 1.21
A prospective surveillance model for rehabilitation for women with breast cancer. Cancer (2012) 1.21
The future of research that promotes cancer screening. Cancer (2004) 1.18
Fecal occult blood testing beliefs and practices of U.S. primary care physicians: serious deviations from evidence-based recommendations. J Gen Intern Med (2010) 1.16
Toward standardizing and reporting colorectal cancer screening indicators on an international level: The International Colorectal Cancer Screening Network. Int J Cancer (2011) 1.15
Restored plasticity in a mouse model of neurofibromatosis type 1 via inhibition of hyperactive ERK and CREB. Eur J Neurosci (2007) 1.10
Validation for clinical use of a novel HIV-2 plasma RNA viral load assay using the Abbott m2000 platform. J Clin Virol (2012) 1.10
Prolonged survival of a murine model of cerebral malaria by kynurenine pathway inhibition. Infect Immun (2005) 1.09
Early detection of breast cancer in countries with limited resources. Breast J (2003) 1.08
Permissive and repulsive cues and signalling pathways of axonal outgrowth and regeneration. Int Rev Cell Mol Biol (2008) 1.06
Mutator suppression and escape from replication error-induced extinction in yeast. PLoS Genet (2011) 1.05
American cancer society guideline for the early detection of cervical neoplasia and cancer. J Low Genit Tract Dis (2003) 1.04
The evolving role of MRI in the detection and evaluation of breast cancer. N Engl J Med (2007) 1.03
Promoting cancer screening: Learning from experience. Cancer (2004) 1.02
Kynurenine pathway inhibition reduces central nervous system inflammation in a model of human African trypanosomiasis. Brain (2009) 1.02
The quality of colonoscopy services--responsibilities of referring clinicians: a consensus statement of the Quality Assurance Task Group, National Colorectal Cancer Roundtable. J Gen Intern Med (2010) 1.02
Radiologist agreement for mammographic recall by case difficulty and finding type. J Am Coll Radiol (2012) 1.01
Long-term incidence of breast cancer by trial arm in one county of the Swedish Two-County Trial of mammographic screening. Cancer (2012) 1.01
Inflammatory status and kynurenine metabolism in rheumatoid arthritis treated with melatonin. Br J Clin Pharmacol (2007) 1.00
Epistatic effects of potassium channel variation on cardiac repolarization and atrial fibrillation risk. J Am Coll Cardiol (2012) 1.00
Kynurenine pathway metabolism in patients with osteoporosis after 2 years of drug treatment. Clin Exp Pharmacol Physiol (2006) 0.98
Prostate cancer screening 2010: updated recommendations from the American Cancer Society. J Natl Med Assoc (2010) 0.98
Measuring the modified early warning score and the Rothman index: advantages of utilizing the electronic medical record in an early warning system. J Hosp Med (2013) 0.97
Effect of radiologists' diagnostic work-up volume on interpretive performance. Radiology (2014) 0.96
Electrochemical and in vitro evaluation of the redox-properties of kynurenine species. Biochem Biophys Res Commun (2003) 0.96
Toxicological and pathophysiological roles of reactive oxygen and nitrogen species. Toxicology (2010) 0.96
Angiogenesis in old-aged subjects after ischemic stroke: a cautionary note for investigators. J Angiogenes Res (2010) 0.96
Single nucleotide polymorphism in hsa-mir-196a-2 and breast cancer risk: a case control study. Twin Res Hum Genet (2011) 0.96
The role of MRI in breast cancer screening. J Natl Compr Canc Netw (2009) 0.95
Modern day relevance of William Hunter's approach to teaching "The organ of hearing". Clin Anat (2013) 0.95
Screening for breast cancer. Surg Oncol Clin N Am (2005) 0.95
Flow rates and warming efficacy with Hotline and Ranger blood/fluid warmers. Anesth Analg (2004) 0.95
Trends in colorectal cancer screening with home-based fecal occult blood tests in adults ages 50 to 64 years, 2000-2008. Cancer (2012) 0.94
Selective subunit antagonists suggest an inhibitory relationship between NR2B and NR2A-subunit containing N-methyl-D: -aspartate receptors in hippocampal slices. Exp Brain Res (2004) 0.94
Levels of purine, kynurenine and lipid peroxidation products in patients with inflammatory bowel disease. Adv Exp Med Biol (2003) 0.94
Responses of differentiated MC3T3-E1 osteoblast-like cells to reactive oxygen species. Eur J Pharmacol (2008) 0.94
Anthelmintic screening of Sub-Saharan African plants used in traditional medicine. J Ethnopharmacol (2009) 0.93
Mammographic interpretive volume and diagnostic mammogram interpretation performance in community practice. Radiology (2011) 0.93
A role for RhoB in synaptic plasticity and the regulation of neuronal morphology. J Neurosci (2010) 0.93
Understanding the complexity of IgE-related phenotypes from childhood to young adulthood: a Mechanisms of the Development of Allergy (MeDALL) seminar. J Allergy Clin Immunol (2012) 0.93
Associations between management, climate, and Escherichia coli O157 in the faeces of feedlot cattle in the Midwestern USA. Prev Vet Med (2004) 0.92
HIV-2 integrase variation in integrase inhibitor-naïve adults in Senegal, West Africa. PLoS One (2011) 0.91
An estrogen model: the relationship between body mass index, menopausal status, estrogen replacement therapy, and breast cancer risk. Comput Math Methods Med (2012) 0.91
New advances in the rehabilitation of CNS diseases applying rTMS. Expert Rev Neurother (2007) 0.91
Development of (E)-2-((1,4-dimethylpiperazin-2-ylidene)amino)-5-nitro-N-phenylbenzamide, ML336: Novel 2-amidinophenylbenzamides as potent inhibitors of venezuelan equine encephalitis virus. J Med Chem (2014) 0.89
Diagnostic mammography: identifying minimally acceptable interpretive performance criteria. Radiology (2013) 0.89